Presence of EBNA in nasopharyngeal carcinoma and control patient tissues related to EBV serology.
D000231:Adenocarcinoma, Papillary / Q000276:immunology; D000956:Antigens, Viral / Q000032:analysis*; D002213:Capsid / Q000276:immunology; D002294:Carcinoma, Squamous Cell / Q000276:immunology; D002467:Cell Nucleus / Q000276:immunology; D005260:Female; D006258:Head and Neck Neoplasms / Q000276:immunology; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D008297:Male; D009092:Mucous Membrane / Q000276:immunology; D009296:Nasal Cavity; D009303:Nasopharyngeal Neoplasms / Q000175:diagnosis / Q000276:immunology*; D009305:Nasopharynx / Q000276:immunology; D009669:Nose Neoplasms / Q000276:immunology; D014066:Palatine Tonsil / Q000276:immunology; D012698:Serologic Tests
D000956:Antigens, Viral; D007070:Immunoglobulin A; D007074:Immunoglobulin G